1,618 results
·
30ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 3
×
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·WAVELIGHT ALLEGRETTO WAVE EXCIMER LASER SYSTEM
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·LADAR VISION EXCIMER LASER SYSTEM (HYPEROPIA)
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·LASERSIGHT LASERSCAN LSX EXCIMER LASER SYSTEM FOR LASER-ASSITED IN SITU KERATOMILEUSIS (LASIK)
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·TECHNOLAS 217A EXCIMER LASER SYSTEM
Fluorescence In Situ Hybridization, Chromosome 17p Deletion (Tp53)
FDA Pre-Market Approval
FDA Class 3
·Vysis CLL FISH Probe Kit
Fluorescence In Situ Hybridization, Chromosome 17p Deletion (Tp53)
FDA Pre-Market Approval
FDA Class 3
·Vysis CLL FISH Probe Kit
Fluorescence In Situ Hybridization, Chromosome 17p Deletion (Tp53)
FDA Pre-Market Approval
FDA Class 3
·Vysis CLL FISH Probe Kit
Fluorescence In Situ Hybridization, Chromosome 17p Deletion (Tp53)
FDA Pre-Market Approval
FDA Class 3
·Vysis CLL FISH Probe Kit
Fluorescence In Situ Hybridization, Chromosome 17p Deletion (Tp53)
FDA Pre-Market Approval
FDA Class 3
·Vysis CLL Fish Probe Kit
Implant, Dermal, For Aesthetic Use In The Hands
FDA Pre-Market Approval
FDA Class 3
·Restylane Lyft with Lidocaine
Fluorescence In Situ Hybridization, Chromosome 17p Deletion (Tp53)
FDA Pre-Market Approval
FDA Class 3
·VYSIS CLL FISH PROBE KIT
Implant, Dermal, For Aesthetic Use In The Hands
FDA Pre-Market Approval
FDA Class 3
·RADIESSE INJECTABLE IMPLANT
Fluorescence In Situ Hybridization, Chromosome 17p Deletion (Tp53)
FDA Pre-Market Approval
FDA Class 3
·Vysis CLL FISH Probe Kit
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·LADARVISION 4000 EXCIMER LASER SYSTEM
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·NIDEK EC-5000 EXCIMER LASER SYSTEM
Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement
FDA Pre-Market Approval
FDA Class 3
·Vysis ALK Break Apart FISH Probe Kit
Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement
FDA Pre-Market Approval
FDA Class 3
·VYSIS ALK BREAK APART FISH PROBE KIT AND PROBECHEK ALK NEGATIVE CONTROL SLIDES
Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement
FDA Pre-Market Approval
FDA Class 3
·Vysis ALK Break Apart FISH Probe Kit
Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement
FDA Pre-Market Approval
FDA Class 3
·VYSIS ALK BREAK APART FISH PROBE KIT.
Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement
FDA Pre-Market Approval
FDA Class 3
·VYSIS ALK BREAK APART FISH PROBE KIT